Cresco Labs Inc. carries a market capitalization of 307.82M, placing it among publicly traded companies globally. Its enterprise value stands at 780.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 307.82M |
| Enterprise Value | 780.18M |
Cresco Labs Inc. currently has 370.50M shares outstanding.
| Shares Outstanding | 370.50M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.50, and the price-to-book ratio stands at 1.44.
| PE Ratio | N/A |
| PS Ratio | 0.50 |
| PB Ratio | 1.44 |
| P/TBV Ratio | -1.25 |
| P/FCF Ratio | 4.08 |
| P/OCF Ratio | 8.63 |
On an enterprise value basis, Cresco Labs Inc. trades at an EV/EBITDA multiple of 6.02 and an EV/FCF ratio of 4.71. The EV/Sales ratio of 1.22 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.47 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.22 |
| EV / EBITDA | 6.02 |
| EV / EBIT | 10.47 |
| EV / FCF | 4.71 |
Cresco Labs Inc. maintains a current ratio of 2.51, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 240.28, indicating elevated leverage, while an interest coverage ratio of 2.16 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.51 |
| Quick Ratio | 0.72 |
| Debt / Equity | 240.28 |
| Debt / EBITDA | 4.53 |
| Interest Coverage | 2.16 |
| Return on Equity (ROE) | -47.42 |
| Return on Assets (ROA) | -10.46 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -17.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.28 |
Over the trailing twelve months, Cresco Labs Inc. has paid 44.53M in income taxes, reflecting an effective tax rate of 606.49.
| Income Tax | 44.53M |
| Effective Tax Rate | 606.49 |
Cresco Labs Inc.'s stock has gained approximately 70.39216% over the past 52 weeks. The 50-day moving average sits at 0.96, while the 200-day moving average is 1.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | 70.39216% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 1.08 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Cresco Labs Inc. generated 641.42M in revenue and converted that into -134.05M in net income, yielding earnings per share of -0.40. EBITDA reached 129.67M, while operating income came in at 74.53M.
| Revenue | 641.42M |
| Gross Profit | 321.39M |
| Operating Income | 74.53M |
| Pretax Income | -97.30M |
| Net Income | -134.05M |
| EBITDA | 129.67M |
| EBIT | 74.53M |
| Earnings Per Share (EPS) | -0.40 |
Cresco Labs Inc. holds 32.35M in cash and equivalents against 586.78M in total debt, resulting in a net debt position of 393.25M. Total book value stands at 220.33M, with working capital of 148.50M providing operational flexibility.
| Cash & Cash Equivalents | 32.35M |
| Total Debt | 586.78M |
| Net Debt | 393.25M |
| Equity (Book Value) | 220.33M |
| Book Value Per Share | 0.62 |
| Working Capital | 148.50M |
Cresco Labs Inc. produced 36.80M in operating cash flow over the past twelve months. After subtracting -41.07M in capital expenditures, free cash flow totaled -4.27M - equivalent to -0.01 per share.
| Operating Cash Flow | 36.80M |
| Capital Expenditures | -41.07M |
| Free Cash Flow | -4.27M |
| FCF Per Share | -0.01 |
Cresco Labs Inc. operates with a gross margin of 50.11, reflecting its pricing power and cost economics. The operating margin of 11.62 and net profit margin of -20.90 provide insight into operational efficiency.
| Gross Margin | 50.11 |
| Operating Margin | 11.62 |
| Pretax Margin | -15.17 |
| Profit Margin | -20.90 |
| EBITDA Margin | 20.22 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 26.77 |
| FCF Yield | 24.52 |
Cresco Labs Inc.'s most recent stock split took place on December 3, 2018 with a 812:1 split ratio.
| Last Split Date | 12/3/2018 |
| Split Ratio | 812:1 |
Cresco Labs Inc. posts an Altman Z-Score of -1.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.31 |